IMMUNIZATION SUMMARY - unicef.org

1 IMMUNIZATION SUMMARY . A statistical reference containing data through 2011. (The 2013 edition). CD-ROM. DISCLAIMER: The data in this edition supersede all historical inside data previously published by unicef and WHO. Version en fran ais sur CD-ROM. Versi n en espa ol en CD-ROM. IMMUNIZATION SUMMARY . A statistical reference containing data through 2011. See inside back cover for CD-ROM. CONTENTS. iv Annual vii Indicative viii Trends: Regional xi Maps: Global xv Notes on indicators and xix Countries and xxiii Antigua and Congo, Democratic Republic of Cook Costa C te d' Iran (Islamic Republic of)..79. Czech Belize ..18 Dominican Bosnia and El Korea, Democratic Equatorial People's Republic Korea, Republic Brunei Burkina Lao People's Democratic Cape Central African ii Papua New Syrian Arab Tanzania, United Republic Marshall Russian The former Yugoslav Republic of Micronesia Saint Kitts and (Federated States of).

2 112 Saint Saint Vincent and the Trinidad and San Sao Tome and Saudi United Arab New Sierra United United Solomon Venezuela occupied Palestinian South (Bolivarian South Republic of)..191. Viet Sri Glossary of 196. iii INTRODUCTION. Tracking, evaluating and sharing information pro- vides a vital tool for understanding IMMUNIZATION coverage. Statistics on levels and trends are used to monitor the performance of services at local, national and international levels. They guide cam- paigns to eradicate polio, control measles and eliminate neonatal tetanus. They identify areas of weak system performance and reveal areas where focused attention and extra resources may be required. And, when deciding whether to introduce a vaccine, IMMUNIZATION levels and trends are one important consideration.

3 The numbers for a single vaccine can provide vital information for national and global action. Coverage levels for the diphtheria and tetanus toxoid with per- tussis vaccine (DTP), for example, are considered to be good indicators of health system performance. In addition, some funding agencies, such as the GAVI Alliance, often consider IMMUNIZATION cover- age levels when reviewing applications for financial and technical support, although coverage estimates alone are insufficient to constitute a sole criterion for determining whether a national IMMUNIZATION pro- gramme has achieved certain performance levels. This reference book, jointly produced by the United Nations Children's Fund ( unicef ) and the World Health Organization (WHO), presents detailed statis- tics on the performance of national and district-level IMMUNIZATION systems in 195 countries and territo- ries.

4 It provides an overview of key aspects, including: Basic indicators from WHO and unicef , the United Nations Population Division and the World Bank for each country or territory. Trends in national and territorial coverage for eight major antigens. District-level performance in achieving coverage with DTP and measles vaccines. iv Measles control activities, including coverage achieved through routine services and informa- tion on national measles campaigns. The most current IMMUNIZATION schedule reported by each country or territory. A copy of the most recent data collection form can be found on the CD-ROM on the inside back cover of this booklet. Background documentation and data can also be downloaded, along with further informa- tion and electronic copies of this book, from the following websites: unicef : WHO: data/en/.

5 V ANNUAL UPDATES. Table 1: Indicative budget prices for major antigens, 2013. The prices listed in the table below are subject to change. unicef Supply Division provides this information for preliminary budget planning only. Full names of these vaccines appear in the Glossary of Acronyms, p. 196. Vaccine (doses per vial). BCG BCG-20. DT DT-10. DTP DTP-10. DTPHepHib DTP-HepB-Hib-1 (Liquid) non-GAVI. DTP-HepB+Hib-2 (Liquid + Lyophilized) non-GAVI. DTP-HepB-Hib-1 (Liquid) GAVI. DTP-HepB-Hib-10 (Liquid) GAVI. DTP-HepB+Hib-2 (Liquid + Lyophilized) GAVI. DTPHib DTP+Hib-1 (Lyophilized) non-GAVI. DTP+Hib-10 (Lyophilized) non-GAVI. HepB HepB-1. HepB-10. HepB-1 adult (1 ml). HepB-10 adult (10 ml). Hib Hib-1 (Lyophilized). Influenza Influenza-10. Influenza-20.

6 MCV Mea-10. MenAC Meningitis AC PS-10. MMR MMR-1 (L-Zagreb strain). MMR-1 (Urabe strain). MMR-5 (L-Zagreb strain). MMR-10 (Urabe strain). MMR-10 (L-Zagreb strain). MR MR-10. OPV OPV-10. OPV-20. bOPV bOPV-20. mOPV mOPV1-20. Pneumococcal Pneumococcal-1* GAVI (13-val). Pneumococcal-2* GAVI (10-val). Pneumococcal-1 non-GAVI (13-val). Pneumococcal-1 non-GAVI (10-val). Rotavirus RV 1-1** GAVI. RV 1-1 non-GAVI. RV 5-1** GAVI. RV 5-1 non-GAVI. Td Td-10. TT TT-10. TT-20. Yellow fever YF-5. YF-10. * The price of RV1-1 vaccines contracted with supplier is EUR per dose. Therefore, the price in US$ will fluctuate throughout the year. The price indicated in this table is based on the UN rate of exchange as of 1 August 2012. ** Vaccine prices to suppliers are initially US$7; however, AMC donors will assume a portion of the price so that in 2012, countries pay a maximum of US$ viii Recommended budget price, 2013.

7 (US$ per vial) (US$ per dose). ix Table 2: Indicative budget price for IMMUNIZATION devices, 2013. These prices are subject to change. unicef Supply Division provides this information for preliminary budget planning only. Device (box of 100, Recommended budget unless otherwise stated) price, 2013 (US$ per box). BCG autodisable syringe, ml BCG autodisable syringe, ml Autodisable syringe, ml Reconstitution syringe, 2 ml, with needle Re-use prevention feature syringe, 2 ml, with fixed needle Reconstitution syringe, 5 ml, with needle Re-use prevention feature syringe, 5 ml, with fixed needle Re-use prevention feature syringe with SIP, 5 ml, with fixed needle Reconstitution syringe, 10 ml, with needle Re-use prevention feature syringe with SIP, 10 ml, with fixed needle Safety box, 5 l (box of 25) x TRENDS: REGIONAL.

8 PROGRESS TOWARDS. MDG4, 1980 - 2011. Note: The list of countries and territories in MDG regions appears online at the United Nations Statistics Division website Millennium Development Goals Indicators' < >. xii MCV coverage 2011. 2010. 2009. 2008. 2007. 2006. 2005. 2004. 2003. 2002. 2001. 2000. 1999. 1998. 1997. 1996. 1995. 1994. 1993. 1992. 1991. 1990. 1985. 1980. Global 84 85 84 83 82 80 77 76 74 72 72 72 71 71 71 73 73 71 70 69 68 72 47 16. MDG regions Caucasus and Central Asia 95 94 92 93 93 93 94 94 94 91 93 93 91 91 91 89 86 77 81 77 .. Developed countries 92 92 93 93 94 94 93 93 92 92 91 91 91 89 89 89 87 85 83 81 83 84 80 63. Eastern Asia 99 99 99 97 94 93 87 87 86 86 85 84 84 82 82 83 80 76 82 87 92 98 87 1. Latin America 94 94 96 96 95 95 94 95 96 94 95 94 93 91 90 85 86 83 83 84 81 77 61 43.

9 Caribbean 76 76 76 76 75 76 77 78 77 78 78 76 75 76 74 75 74 73 70 67 68 64 51 20. Northern Africa 96 96 95 92 96 96 95 93 93 93 94 93 92 93 92 92 89 89 88 87 87 84 66 22. Oceania 64 59 59 58 63 68 66 63 66 65 61 66 67 64 56 39 52 47 42 73 73 70 36 4. South-eastern Asia 89 90 88 88 86 86 84 85 82 80 80 80 81 82 82 82 75 75 74 72 71 70 26 0. Southern Asia 77 77 76 77 77 74 69 65 62 59 59 58 58 56 58 65 70 67 61 55 48 57 9 2. Sub-Saharan Africa 74 75 73 68 66 64 61 59 56 54 53 53 50 52 53 53 54 54 50 49 52 56 32 6. Western Asia 86 86 87 86 83 83 84 82 79 82 86 86 85 84 78 76 73 74 74 72 73 77 54 17. unicef regions Central and Eastern Europe and CIS 94 93 94 96 96 96 93 90 89 90 92 91 89 88 87 83 80 79 81 80 83 85 89 73. East Asia and Pacific 95 95 95 93 91 90 86 86 84 83 83 83 83 82 82 83 78 75 79 82 85 89 67 1.

10 Eastern and Southern Africa 79 79 76 73 72 69 65 65 64 64 63 60 60 64 66 67 64 66 60 57 58 61 42 8. Industrialised Countries 92 92 93 93 93 93 93 92 92 91 91 91 90 89 90 90 88 86 82 81 82 83 72 52. Latin America and the Caribbean 93 93 94 94 94 94 93 94 95 93 94 93 92 90 89 84 85 82 82 83 80 76 60 42. Middle East and North Africa 90 90 89 88 87 86 86 86 85 85 85 86 85 85 83 84 81 80 80 79 78 79 55 20. South Asia 77 77 76 77 76 73 68 64 60 58 58 57 56 54 57 64 69 66 59 53 47 56 6 0. West and Central Africa 69 71 69 63 59 59 56 52 49 44 43 45 40 41 40 41 44 44 41 41 47 50 24 4. WHO regions African 75 75 73 69 66 64 61 59 57 54 54 54 51 53 54 54 55 56 52 51 54 58 35 6. American 92 92 94 94 93 93 93 94 94 93 93 92 92 91 90 86 86 84 83 83 82 80 68 51.